Built by someone who's been there.

The problem wasn't understanding cybersecurity—it was proving it to regulators. We had devices in the field running different firmware versions, legacy builds in clinics that couldn't sync their upgrade schedules, companion apps two versions behind. Each one needed continuous surveillance, exploitability assessments, and audit trails linking SBOMs to CVEs to risk decisions.

The tools I tried fell into two camps: enterprise platforms that hid compliance features behind “contact sales” walls and NDAs, or developer-centric scanners that handed me JSON dumps and called it “regulator-ready.” Neither understood that medical devices aren't rolling web deployments. Neither gave me what a Notified Body actually wanted to see.

I was angry—not dramatically, but constantly. Angry at vendors treating clarity as a premium upgrade. Angry at myself for duct-taping spreadsheets into a “process” that wouldn't survive me taking a day off. Mostly, I was tired of being the bottleneck between good engineering and market access.

Threat Detective treats each deployed version as a first-class citizen—not an afterthought. Legacy builds in clinics get the same continuous monitoring as your current release. When a CVE drops, you see exactly which versions are affected, capture exploitability decisions with clear rationale, link to risk files, and generate reports that look like what Notified Bodies and FDA reviewers actually want to see.

No enterprise theater. Pricing is transparent: per device, same features, available today. No “contact sales” gates hiding the basics. Reports come out formatted for MDR Annex I, MDCG 2019-16, IEC 81001-5-1, and FDA submissions—ready to drop into your technical file without midnight reformatting sessions.

The goal isn't to make you a cybersecurity expert. It's to give you a defensible, repeatable process that proves continuous surveillance without spreadsheet acrobatics. So you can focus on building safe devices instead of becoming the formatter of last resort.